Scpharmaceuticals Inc (SCPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Scpharmaceuticals Inc-Aktie (SCPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	36.50% 16.04	11.75	12.15	10.03	8.054
Cost Of Revenue	44.37% 5.011	3.471	3.965	3.311	2.30
Gross Profit	33.20% 11.03	8.281	8.185	6.715	5.754
Operating Expenses	2.74% 25.32	26.04	24.53	24.86	20.18
Interest Income/Expense	1.16% 1.401	1.385	1.485	1.85	2.134
Benefits Costs and Expenses	8.16% 34.06	31.49	31.00	45.13	25.14
Costs And Expenses	8.16% 34.06	31.49	31.00	45.13	25.14
Operating Income/Loss	19.50% -14.29	-17.76	-16.34	-18.15	-14.43
Income/Loss From Continuing Operations Before Tax	8.70% -18.02	-19.74	-18.84	-35.10	-17.09
Income/Loss From Continuing Operations After Tax	8.70% -18.02	-19.74	-18.84	-35.10	-17.09
Net Income/Loss	8.70% -18.02	-19.74	-18.84	-35.10	-17.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.08% 53.72	53.68	3.0028	46.56	38.98
Diluted Average Shares	0.08% 53.72	53.68	3.0028	46.56	38.98
Basic Earnings Per Share	8.11% -0.34	-0.37	-0.31	-0.75	-0.44
Diluted Earnings Per Share	8.11% -0.34	-0.37	-0.31	-0.75	-0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$38.39

1.08%

INCY

$95.41

0.72%

GMAB

$31.31

3.07%

BNTX

$94.81

1.24%

ONC

$319.06

0.55%

INSM

$197.01

0.91%